Jong Duk Lee

Combination chemotherapy with irinotecan and cisplatin in elderly patients (>or= 65 years) with extensive-disease small-cell lung cancer.

I. Hwang, M. Kang, J. Hahm, 2008, Lung cancer.

Clinical Significance of ABCG2 Haplotype-tagging Single Nucleotide Polymorphisms in Patients With Unresectable Non–Small Cell Lung Cancer Treated With First-line Platinum-based Chemotherapy

H. Ling, S. Oh, Seok-Hyun Kim, 2015, American journal of clinical oncology.

Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy.

S. Oh, Seok-Hyun Kim, Suee Lee, 2012, Lung cancer.

Phase II Trial of Biweekly Chemotherapy with Docetaxel and Cisplatin in High-Risk Patients with Unresectable Non-Small Cell Lung Cancer

Seok-Hyun Kim, Gyeong-Won Lee, Y. Cho, 2013, Chemotherapy.

Fixed-dose rate infusion of gemcitabine and weekly cisplatin in elderly or poor performance status patients with unresectable non-small cell lung cancer

M. Kang, Seok-Hyun Kim, Gyeong-Won Lee, 2009, Cancer Chemotherapy and Pharmacology.

Phase II study of a biweekly schedule of docetaxel and cisplatin in patients with metastatic non-small cell lung cancer.

Seok-Hyun Kim, Gyeong-Won Lee, Y. Cho, 2010, Lung cancer.

Phase II study of a biweekly schedule of docetaxel and cisplatin in patients with metastatic non-small cell lung cancer.

Seok-Hyun Kim, Gyeong-Won Lee, Y. Cho, 2010, Lung cancer.

Phase II Trial of Biweekly Chemotherapy with Docetaxel and Cisplatin in High-Risk Patients with Unresectable Non-Small Cell Lung Cancer

Seok-Hyun Kim, Gyeong-Won Lee, Y. Cho, 2013, Chemotherapy.